Understanding host-gut microbiota interactions to develop a therapeutic/preventive strategy toward SARS-CoV-2 infection
- Funded by RIKEN
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
RIKENPrincipal Investigator
Kenya HondaResearch Location
JapanLead Research Institution
Laboratory for Gut Homeostasis, Center for Integrative Medical SciencesResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
N/ASpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Not applicableBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
In collaboration with the University of Tokyo and Keio University, we will collect fecal samples from patients recovered from COVID-19 and search for bacterial strains that can enhance antibody response against the virus. Since we recently identified serine protease-degrading bacterial strains, we will evaluate the effect of these strains against intestinal coronavirus infection.